We suggest that the establishment of a novel approach focusing on IFN-α and corresponding cytokines in the early phase of SARS-CoV-2 infection would contribute to the early detection of patients with COVID-19 at a high risk of respiratory failure. This evidence concerns the gene IFNA1 and COVID-19.